Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna G Kondic

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|August 18, 2024
Visual predictive check of longitudinal models and dropoutChuanpu Hu, Anna G Kondic, Amit Roy
CPT: Pharmacometrics & Systems Pharmacology|November 11, 2025
Integrating MBMA and QSP to Identify Key Covariates and Predict Treatment Outcomes in Relapsed/Refractory Multiple MyelomaZeel Shah, Clifton M Anderson, Kevin D McCormick, et al.
Clinical Pharmacology and Therapeutics|December 31, 2025
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I Kapitanov, Justin C Earp, Kapil Gadkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2018
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic ClearanceDavid C Turner, Anna G Kondic, Keaven M Anderson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 3, 2017
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall responseHongshan Li, Jingyu Yu, Chao Liu, et al.
Journal for Immunotherapy of Cancer|August 10, 2019
Immunogenicity of pembrolizumab in patients with advanced tumorsMarianne J H van Vugt, Julie A Stone, Rik H J M M De Greef, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pharmacokinetics and Pharmacodynamics|August 18, 2024
Visual predictive check of longitudinal models and dropoutChuanpu Hu, Anna G Kondic, Amit Roy
CPT: Pharmacometrics & Systems Pharmacology|November 11, 2025
Integrating MBMA and QSP to Identify Key Covariates and Predict Treatment Outcomes in Relapsed/Refractory Multiple MyelomaZeel Shah, Clifton M Anderson, Kevin D McCormick, et al.
Clinical Pharmacology and Therapeutics|December 31, 2025
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I Kapitanov, Justin C Earp, Kapil Gadkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2018
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic ClearanceDavid C Turner, Anna G Kondic, Keaven M Anderson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 3, 2017
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall responseHongshan Li, Jingyu Yu, Chao Liu, et al.
Journal for Immunotherapy of Cancer|August 10, 2019
Immunogenicity of pembrolizumab in patients with advanced tumorsMarianne J H van Vugt, Julie A Stone, Rik H J M M De Greef, et al.
Pageof 1